Saad Zafar Usmani, MD, FACP, chief of Plasma, Levine Cancer Institute, shares his advice for the management of early relapse in patients with multiple myeloma.
According to Usmani, one size does not fit all. Physicians should consider each regimen that could potentially be used for first relapse to decide which option is best for the patient. If there are 2 regimens with similar benefit, convenience for the patient should also be considered
